| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | CA2594255A1 Novel pyridine compounds |
| 07/13/2006 | CA2592840A1 Adipose-derived stem cells for tissue regeneration and wound healing |
| 07/12/2006 | EP1679316A1 Stable vitamin b6 derivative |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 07/12/2006 | EP1679068A1 Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 07/12/2006 | EP1679067A1 Concurrent drugs |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678161A2 Thioether-substituted benzamides as inhibitors of factor xa |
| 07/12/2006 | EP1677829A1 Fibrinogen targetting microparticles for promoting haemostasis |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1237559B1 Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | EP0876396B1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 07/12/2006 | CN1802370A Aroyl semicarbazide derivatives against thromboembolic diseases |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1800133A Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal |
| 07/12/2006 | CN1799576A Chinese medicinal extract, its preparation process and quality control method |
| 07/12/2006 | CN1799575A Chinese medicinal dispersible tablet, its preparation process and quality control method |
| 07/12/2006 | CN1799553A Thrombus dissolving tablet and preparation |
| 07/12/2006 | CN1799542A Hawthorn fruit total flavone phospholipid composition and its preparation method |
| 07/12/2006 | CN1799407A Aloe and pollen tablet and its production method |
| 07/12/2006 | CN1263763C Process for extracting ginkgolide |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263483C Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
| 07/12/2006 | CN1263472C Gingko drop pill for prevention and treatment of cardiovascular and cerebrovascular disease |
| 07/11/2006 | US7074940 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 07/11/2006 | US7074820 Amidino derivatives and their use as thrombin inhibitors |
| 07/11/2006 | US7074817 For treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/06/2006 | WO2006070934A1 Crystal of bicyclic fused heterocyclic derivative, process for production thereof, and use thereof |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060148901 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein |
| 07/06/2006 | US20060148879 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases |
| 07/06/2006 | US20060148810 Treatment of amm |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148745 DNA-based aptamers for human cathepsin G |
| 07/06/2006 | US20060148698 Storage-stable fibrinogen solutions |
| 07/06/2006 | US20060148689 A peptide consisting of a sequence comprising a tripeptide and tetrapeptide linked or existing separately with specific recognition of lipid vectors, particularly negativelycharged phosphatides on cell surfaces; stability; labels;fluorescence; imaging contrast agents; kitsanalyzing; diagnosis/medical |
| 07/06/2006 | US20060148683 Detection and treatment of intravascular lesions |
| 07/06/2006 | US20060148038 Thrombin cleavable factor x analogues |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments |
| 07/06/2006 | DE102004062475A1 Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung Solid, orally administered pharmaceutical dosage forms with modified release |
| 07/06/2006 | DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines |
| 07/06/2006 | DE102004061750A1 Heteroaryl-substituierte Pyrazoline Heteroaryl substituted pyrazolines |
| 07/06/2006 | DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines |
| 07/06/2006 | DE102004061747A1 Thiophen-substituierte Pyrazoline Thiophene-substituted pyrazolines |
| 07/05/2006 | EP1676920A2 Anticoagulant fusion protein anchored to cell membrane |
| 07/05/2006 | EP1676919A1 Modified vitamin K-dependent polypeptides |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676860A1 Process for producing antithrombin iii composition |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
| 07/05/2006 | EP1675872A1 Virally-safe factor viii with a low content of higher multimers |
| 07/05/2006 | EP1675579A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/05/2006 | EP1675569A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | CN1798771A Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 07/05/2006 | CN1798739A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 07/05/2006 | CN1795927A Composite of total flavone phospholipid of safflower, and preparation method |
| 07/05/2006 | CN1262649C Method for producing parathyroid hormone derivative by recombination and expression carrier used thereof |
| 07/05/2006 | CN1262566C Low oxygen affinity mutant hemoglobins |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/05/2006 | CN1262212C Health care beverage |